Chronic Obstructive Pulmonary Disease – Emerging Therapies – Asthma & COPD | Salmeterol & Fluticasone Generic Wave 2 (US)

Table of contents

  • Chronic Obstructive Pulmonary Disease - Emerging Therapies - Asthma & COPD | Salmeterol & Fluticasone Generic Wave 2 (US)
    • Asthma and COPDu00a0Emerging Therapies Salmeterol / Fluticasone Genericu00a0US Wave 2 (October 2019)

launch Related Market Assessment Reports